LMNB1 and familial pancreatic carcinoma: Previous studies showed that LMNB1 was overexpressed in pancreatic cancer, liver cancer and prostate cancer (Butin-Israeli et al., 2012; Irianto et al., 2016) and its overexpression was associated with poor clinical outcomes in the cervical (Yang et al., 2019) and colon (Izdebska et al., 2018) cancers.